Fluorouracil and Biological Therapy in Treating Patients With Metastatic Kidney or Colorectal Cancer
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing
so they stop growing or die. Biological therapies use different ways to stimulate the immune
system and stop cancer cells from growing. Combining chemotherapy with biological therapy may
kill more tumor cells.
PURPOSE: Phase I trial to study the effectiveness of fluorouracil combined with biological
therapy in treating patients who have metastatic kidney or colorectal cancer.